Cell and Gene Therapies
-15%
portes grátis
Cell and Gene Therapies
Abutalib, Syed A.; Bollard, Catherine; Perales, Miguel-Angel
Springer International Publishing AG
12/2018
288
Dura
Inglês
9783319543673
15 a 20 dias
728
Descrição não disponível.
Historical perspective and current focus.- Part I: Genetically modified T cells (Chimeric antigen receptors and T cell receptors): Chimeric antigen receptor-T cells: Antigen selection, CAR development and future prospects.- Chimeric antigen receptor-T cells for leukemias in children: Methods, data and challenges.- Chimeric antigen receptor-T cells for leukemias in adults- Methods, data and challenges.- Chimeric antigen receptor-T cells for lymphomas: Methods, data and challenges.- T-cell receptors-gene modified T-cells for cancer.- Methods, data and challenges..- Part II: Beyond chimeric antigen receptor and T-cell receptors - Data, Consensus & Challenges: Cytotoxic T cells for infections: From donor-specific to "off the shelf".- Donor lymphocyte infusion in different transplant settings: When and how?- T-regulatory cells: Broadening applicability.- Tumor infiltrating lymphocytes: Current concepts and practices.- Part III: Beyond T-cells: Natural killercells: What have we learned?- Dendritic cells in hematopoietic cell transplantation.- Mesenchymal stem cells: From bench to bedside and back.- Cell Therapies: Regulatory concerns and data collection.- Part IV: Gene Therapy: Gene therapy for hematologic malignancies and in transplant setting .- Gene therapy for nonmalignant disorders.- Future prospects of cell and gene therapies.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Chimeric antigen receptor-T cells;Cytotoxic T cells for infections;Tumor infiltrating lymphocytes;Dendritic cells;Mesenchymal stem cells
Historical perspective and current focus.- Part I: Genetically modified T cells (Chimeric antigen receptors and T cell receptors): Chimeric antigen receptor-T cells: Antigen selection, CAR development and future prospects.- Chimeric antigen receptor-T cells for leukemias in children: Methods, data and challenges.- Chimeric antigen receptor-T cells for leukemias in adults- Methods, data and challenges.- Chimeric antigen receptor-T cells for lymphomas: Methods, data and challenges.- T-cell receptors-gene modified T-cells for cancer.- Methods, data and challenges..- Part II: Beyond chimeric antigen receptor and T-cell receptors - Data, Consensus & Challenges: Cytotoxic T cells for infections: From donor-specific to "off the shelf".- Donor lymphocyte infusion in different transplant settings: When and how?- T-regulatory cells: Broadening applicability.- Tumor infiltrating lymphocytes: Current concepts and practices.- Part III: Beyond T-cells: Natural killercells: What have we learned?- Dendritic cells in hematopoietic cell transplantation.- Mesenchymal stem cells: From bench to bedside and back.- Cell Therapies: Regulatory concerns and data collection.- Part IV: Gene Therapy: Gene therapy for hematologic malignancies and in transplant setting .- Gene therapy for nonmalignant disorders.- Future prospects of cell and gene therapies.
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
